专题:Ocular Oncology and Treatments

This cluster of papers focuses on the research, diagnosis, and treatment of ocular cancers, particularly uveal melanoma and retinoblastoma. It covers topics such as genetic mutations, metastatic disease, various treatment modalities including radiation therapy and intraocular chemotherapy, prognostic factors, and tumor classification.
最新文献
High-throughput screening of drug libraries identifies a new synergistic drug combination for the treatment of retinoblastoma

article Full Text OpenAlex

Independent validation of time to treatment as a prognostic factor in uveal melanoma

article Full Text OpenAlex

Application of artificial intelligence in differentiating IgG4-related ophthalmic disease and orbital MALT lymphoma: a review of radiomics and deep learning advances

article Full Text OpenAlex

Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis

article Full Text OpenAlex

Recurrent Macular Edema Associated With Belzutifan Therapy for Metastatic Renal Cell Carcinoma

article Full Text OpenAlex

Tumour control, eye retention and visual acuity after radiotherapy for choroidal melanoma

article Full Text OpenAlex

Ocular toxicities of targeted therapies and immunotherapies in hematologic malignancies

article Full Text OpenAlex

Factors to Predict 13 or More Sections in Mohs Micrographic Surgery

article Full Text OpenAlex

Characteristics of Uveitis Specialists and Disparities in Geographic Access to Uveitis Care in the United States

article Full Text OpenAlex

Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression

article Full Text OpenAlex

近5年高被引文献
Sebaceous Carcinomas of the Ocular Adnexa: A Clinicopathologic Study of 104 Cases, with Five-Year Follow-up Data

book-chapter Full Text OpenAlex 335 FWCI2.7722

Targeting angiogenesis in oncology, ophthalmology and beyond

review Full Text OpenAlex 296 FWCI49.6843

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

article Full Text OpenAlex 280 FWCI42.69

Advances in the clinical management of uveal melanoma

review Full Text OpenAlex 248 FWCI70.4927

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

article Full Text OpenAlex 227 FWCI64.2402

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

article Full Text OpenAlex 226 FWCI66.1244

Molecular mechanism of VEGF and its role in pathological angiogenesis

review Full Text OpenAlex 209 FWCI16.5681

Explainable AI for Retinoblastoma Diagnosis: Interpreting Deep Learning Models with LIME and SHAP

article Full Text OpenAlex 179 FWCI51.0999

Systemic Therapy for Melanoma: ASCO Guideline Update

review Full Text OpenAlex 170 FWCI26.5608

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial

article Full Text OpenAlex 144 FWCI28.1795